Home Valuation in Life Sciences: A Practical Guide by Boris Bogdan; Ralph Villiger (ISBN: 9783540455653)

Stock photo: cover may vary

Valuation in Life Sciences: A Practical Guide Hardback - 2007 - 1st Edition

Name: Valuation in Life Sciences: A Practical Guide
Price: 39.36 USD
Availability: InStock
ISBN: 9783540455653

by Boris Bogdan; Ralph Villiger

Add to wish list

Browse more copies for sale ↓

Reader reviews for Valuation in Life Sciences: A Practical Guide

Write a review for this book

Important Terms and Guidelines

Please focus on the book’s content and context. Also, add any personal comments as to how you enjoyed the book. Substantiate your likes and dislikes. You may make comparisons to other books.
Reviews must be at least 140 characters in length.
Please do not reveal critical plot elements.
This is not a help line. Contact customer support if you need help.

Your review must not include:

Obscenities, discriminatory language, or other insulting language not suitable for public domain
Advertisements, “spam” content, or references to other products, offers or websites.
Email addresses, URLs, phone numbers, physical addresses or other contact information.
Overly critical comments about other reviews or reviewers
Time-sensitive material (i.e. promotional tours, seminars, lectures, etc.)
Availability, price, or alternative ordering/shipping information

From the publisher

This book is the first complete guide to valuation in life sciences for industry professionals, investors, and academics. Boris Bogdan and Ralph Villiger introduce the characteristics of drug and medical device development, explain how to translate these into the valuation, and provide valuable industry data. After guiding the reader through the theory of valuation, including discounted cash-flow and real options, the authors demonstrate how to value projects, patents, licences, firms and stocks on real-life examples, even treating complex licence and company structures. Special emphasis is put on the practicability of the proposed methods by including many hands-on examples, without compromising on realistic results. Ralph Villiger and Boris Bogdan have written what is sure to become the industry standard reference for valuation of pharmaceutical and biotechnology projects and companies. At a time when the healthcare industry is placing increasing emphasis on licensing and M&A as a core strategy this book provides a firm understanding of the way in which products and businesses can be valued at all stages of their development.

Dr. Martin Buckland, Chief Business Officer, Astex Therapeutics, Cambridge, UK

The book presents a number of innovative ideas, illustrated with practical examples that should improve decision-making in the drug development process, intellectual property evaluation, licensing and sublicensing. The authors make a persuasive case for the use of advanced techniques and the section on worked-examples should be particularly appealing to practitioners.

Dr. Martin Grossmann, Novartis Pharmaceuticals

There is no doubt that this book will become an essentialreference tool for professionals in technology transfer, business developers and biotech companies, as well as the pharmaceutical industry and Life Science investors.

Jean-Pierre Saintouil, Director of Technology Transfer Department, Institut Pasteur, Paris, France

Details

Title Valuation in Life Sciences: A Practical Guide
Author Boris Bogdan; Ralph Villiger
Binding Hardback
Edition number 1st
Edition 1
Pages 249
Volumes 1
Language ENG
Publisher Springer
Publication date February 21, 2007
ISBN 9783540455653 / 3540455655
Weight 1.2 lbs (0.54 kg)
Dimensions 9.21 x 6.14 x 0.63 in (23.39 x 15.60 x 1.60 cm)
Category Business / Economics / Finance
Library of Congress Catalogue Number 2006938913
Dewey Decimal Code 610.6

More Copies for Sale

Stock photo: cover may vary